Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.
Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.
A multicenter study of 344 women between 65 and 98 years of age enrolled in the Cardiovascular Health Study measured levels of total and free testosterone by equilibrium dialysis. Cross-sectional analyses examined associations among total and free testosterone and metabolic syndrome, insulin resistance, and coronary heart disease.
Researchers found a stepwise increase in insulin resistance with increased levels of total (P=.003) and free (P=.02) testosterone and a corresponding decrease in Quantitative Insulin Sensitivity Check Index (P<.001 and P=.002, respectively). Adjusted models also found strong associations between high levels of both total and free testosterone and abdominal obesity and high fasting glucose. Finally, women in the top quartile of total testosterone levels had 3-fold greater odds than women in the bottom quartile of developing metabolic syndrome and 3-fold greater odds than those in the second quartile of developing coronary heart disease.
Patel SM, Ratcliffe SJ, Reilly MP, et al. J Clin Endocrinol Metab. E-pub October 21, 2009. doi:10.1210/jc.2009-0740.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More